Previous Close | 1.2200 |
Open | 1.2202 |
Bid | 0.8928 x 200 |
Ask | 1.5400 x 200 |
Day's Range | 1.1700 - 1.2689 |
52 Week Range | 0.9900 - 4.3000 |
Volume | |
Avg. Volume | 453,742 |
Market Cap | 5.915M |
Beta (5Y Monthly) | 0.61 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Hoth Therapeutics (HOTH) rises on encouraging pre-clinical data demonstrating cognitive benefits of its novel therapeutic candidate, HT-ALZ, in the treatment of Alzheimer's disease.